Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma
Phase 2 Completed
7 enrolled 20 charts
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
Phase 2 Completed
137 enrolled 13 charts
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
Phase 2 Completed
30 enrolled 19 charts
Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
Phase 2 Completed
97 enrolled 35 charts
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
Phase 2 Completed
112 enrolled 12 charts
Sunitinib in Treating Patients With Recurrent Malignant Gliomas
Phase 2 Completed
31 enrolled 6 charts
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
Phase 2 Completed
42 enrolled 11 charts
VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
Phase 2 Completed
58 enrolled 12 charts
Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
Phase 2 Completed
30 enrolled 8 charts
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
Phase 2 Completed
11 enrolled 7 charts
Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase 2 Unknown
Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma
Phase 2 Completed
90 enrolled
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
Phase 2 Unknown
50 enrolled
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
Phase 2 Unknown
87 enrolled
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Phase 2 Completed
30 enrolled
Suramin in Treating Patients With Recurrent Primary Brain Tumors
Phase 2 Completed
Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors
Phase 2 Completed
Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma
Phase 2 Completed
60 enrolled
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
Phase 2 Completed
200 enrolled
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer
Phase 2 Completed
30 enrolled
Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma
Phase 2 Completed
40 enrolled
Talampanel in Treating Patients With Recurrent High-Grade Glioma
Phase 2 Completed